Drug shortages are a persistent public health issue in the US. There is no easy method to scale up production to meet periodic sharp increases in demand, like the one occurring at the moment as a result of the "tripledemic." And there is a limited profit motive to do so, particularly for generics.
Subscribe to:
Post Comments (Atom)
< + > Cellbyte Raises $2.75 Million | Function Health Announces $298M Oversubscribed Series B | Arbiter Emerges from Stealth with $52M
Check out today’s featured companies who have recently raised a round of funding, and be sure to check out the full list of past healthcare ...
-
As I’m sure you know, times are tough. Wages have largely remained the same while prices have risen across the board – and healthcare is no ...
-
Solution Erases Long Phone Holds for Patients, Supports Overwhelmed Medical Front Desk Workers, and Improves Patient Access to Physicians A...
-
Welcome to the weekly edition of Healthcare IT Today Bonus Features . This article will be a weekly roundup of interesting stories, product ...
No comments:
Post a Comment